Arianne Reza

Advancing discussions on programs and contracts tied to the development and support of future combat vessels. Funding to prepare the facility for construction of the future River Class Destroyer fleet and to support the ongoing maintenance of vessels. Interactions with Government officials regarding in-service support for Halifax Class Frigates. Input into the Federal Government's National Shipbuilding Procurement Strategy as it relates to Irving Shipbuilding being selected on October 19, 2011 to build the Combat Vessel work package.

Canada's potential contributions to global security in Europe, NATO, and NORAD With regard to federal measures to assist the Canadian Aerospace sector and advocate for an aerospace and defence industrial strategy. Seeking funding from Strategic Aerospace and Defence Initiative (SADI) & Strategic Innovation Fund (SIF) Industrial and Technological Benefits Educating and advocating for Canada to support its aerospace sector and preserve our country’s Key Industrial Capabilities (KIC) in flight training and simulation.

Canada's potential contributions to global security in Europe, NATO (North Atlantic Treaty Organization), and NORAD (North America Aerospace Defence Command) Working to extend the Operational Training System Program (OTSP) to other RCAF aircraft type training systems. Updates to the NATO Flying Training In Canada program (NFTC) to adjust the operating period. To obtain support from the Canadian government to CAE for procuring contracts to build simulators or to train personnel in foreign countries. To maximize efficiency of visa applications for pilots at various Canadian embassies from which countries that pilots are traveling to Canada to be trained. To ensure future contracts for Defence procurement allow bidding for training to be carved out to a separate process. Defence Procurement Policy to increase the Canadian content on various military programs to be procured by Government

Operational training support project.

Discussing possible change of policy regarding biometrics collection Assist in securing and managing defence and coast guard contracts under the National Shipbuilding Strategy (NSS) and other procurement opportunities. Government Contract Pursued - ship repair and overhaul opportunities with the Government of Canada

The Council of Canadian Innovators (CCI) is engaging with government officials to discuss the alignment between CCI’s priorities and the federal government’s efforts to foster innovation in Canada. These discussions focus on ensuring that government programs and policies effectively support high-growth Canadian technology firms and strengthen the country’s innovation ecosystem. Canadian Sovereign AI Compute Strategy: advocacy was focused on bringing domestic firms into the value chain through policies and measures that provide equal opportunity for Canadian Head Quartered companies. Discussion on the intangible economy, SR&ED, and economic growth as it relates to domestic expenditures for intellectual property filing, as well as a focus on small and medium-sized companies. US Trade - discussed Tariffs and handling of Canada US Mexico Trade Agreement. Sustainable Development Technology Canada (SDTC) to establish a sponsorship agreement related to CCI's Board education training program for the intangible economy. Small Business and Tourism, Changes to Canadian Export Program (CanExport) so it allows more technology companies to apply Procurement – Changes to Request for Proposal (RFP) process to break down large bundles into smaller amounts for Medium and Small Business (SMEs) can apply Health Canada: advocate for an increase of resources for Therapeutics Canada for them to speed up processing times and efficiencies within their department; create working groups and framework with industry leaders and health Canada on digital and data health, and create a therapeutics working group with industry and health Canada. Finance – Changes to Scientific research and experimental development (SR&ED) tax incentive program to make the process easier for Medium and Small Business (SMEs) to apply and report on the current program, to further increase the maximum a SME can apply for Export Development Canada (EDC) to establish a sponsorship agreement related to CCI's Board education training program for the intangible economy. Environment and Climate Change Canada, give input and feedback on the PanCanada Framework, Canada-China agreement for scientific and technological cooperation, and the relationship between Carbon Dioxide (CO2) Emitters & CO2 Reducers. Our focus is on involving Canadian high-growth firms in the policies and programs the government is working on regarding climate change and the greening of government. Discussions on international trade, specifically on the North American Free Trade Agreement with respect to data localisation, labour mobility and tariffs. Defence & Security: advocate for a domestic-focused cybersecurity ecosystem that has Canadian companies at the centre of a national cybersecurity defence policy. Citizenship and immigration – Change the current work visa time lines, seek changes to the the Labour Market Impact Assessment for expatiating and a faster process Changes to Industrial Research Assistance Program (IRAP) to make the process easier for Medium and Small Business (SMEs) to apply and report on the current program, to Increase the maximum amount a SME can apply for Canada Revenue Agency (CRA) - changes to (scientific research and experimental development) SR&ED program with how it is administered and reviewed. Discussed companies SR&ED claims and issues with their processing. Business Development Bank of Canada (BDC) to establish a sponsorship agreement related to CCI's Board education training program for the intangible economy.

Discuss issues related to international competitiveness of the domestic AI industry. Provide subject matter (AI) expertise to the Canadian AI Safety Institute team where it might be helpful across a number of areas including opportunities for research and safety practices. Discussions regarding digital policy and legislation, including as it relates to artificial intelligence (AI) and data protection, privacy and reduction of online harms. Discussions with officials regarding the Canada-US bilateral relationship. AI adoption including updating procurement policies.

Discussions regarding digital policy and legislation, including as it relates to artificial intelligence (AI) and data protection, privacy and reduction of online harms. AI adoption including updating procurement policies. Discuss issues related to international competitiveness of the domestic AI industry. Provide subject matter (AI) expertise to the Canadian AI Safety Institute team where it might be helpful across a number of areas including opportunities for research and safety practices. Discussions with officials regarding the Canada-US bilateral relationship.

Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB). Free trade agreements as they relate to the biopharmaceutical industry. Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations. Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes. Advocacy related to the new Buy Canada policy and the implications of including goods and services related to healthcare delivery, medical treatment, in particular drugs, vaccines and biologicals. Advocacy as it relates to the Government of Canada potential responses to the US Administration Most Favored Nation drug pricing policy Monitoring and engaging on the Government’s national strategy for rare diseases; the Canadian Drug Agency; and the implementation of C64, An Act to Implement pharmacare. Patented Medicine Prices Review Board (PMPRB) amendments to the Patented Medicines Regulations and the related new guidelines. Advocacy on the Regulations Amending the Patent Rules and Certain Regulations Made Under the Patent Act which were published for consultation in Canada Gazette Part I (CGI) on May 18, 2024.1 Share concerns with Canada’s implementation of a patent term adjustment (PTA) system that is not compliant with its trade obligations, as it does not provide a meaningful remedy to patentees who are impacted by unreasonable patent office delays. Advocacy related to the federal government consultation on the review of the Canada US Mexico Trade Agreement Advocacy on the role of the Health Emergency Readiness Canada (HERC) Agency Advocacy with respect to Canada's proposed Countermeasures in Response to United States Tariffs on Canadian goods The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability. Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Drug Agency as well as the review times and processes conducted by Health Canada for the purpose of obtaining a notice of compliance. Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's life sciences & biomanufacturing strategy Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries Engage the Federal Government on Health Canada’s Regulatory Innovation Agenda (Agile Licensing Modernization) to discuss opportunities for further harmonization; flexibility and predictability in the new regulatory framework being develop and its linkage to pillar 5 of the Biomanufacturing and Life Sciences Strategy. Discussions on the procurement of a COVID19 vaccine and therapy Discussions around the World Trade Organization consideration of a TRIPS Patent Waiver and the World Health Organization pandemic treaty proposal Consider amendments to the Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of potential importation legislation in the United States. Advocacy to maintain and increase funding for the National Immunization Strategy and discussions on vaccine procurement.

Advocacy on the creation of the Health Emergency Readiness Canada (HERC) Agency Contribution to the Government Public consultations on Canada-United States-Mexico Agreement to inform Canada’s priorities in preparation for the first joint review of CUSMA by Canada, the United States and Mexico in 2026 and ahead of Canada’s chairing of the 5th meeting of the CUSMA Free Trade Commission, in 2025. Advocacy on the proposed Regulations Amending the Patent Rules and Certain Regulations Made Under the Patent Act which were published for consultation in Canada Gazette Part I (CGI) on May 18, 2024.1 Share concerns with Canada’s implementation of a patent term adjustment (PTA) system that is not compliant with its trade obligations, as it does not provide a meaningful remedy to patentees who are impacted by unreasonable patent office delays. The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability. Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Drug Agency as well as the review times and processes conducted by Health Canada for the purpose of obtaining a notice of compliance. Patented Medicine Prices Review Board (PMPRB) amendments to the Patented Medicines Regulations and the related proposed guidelines. Monitoring and engaging the Government and Parliamentarians on the House of Commons Standing Committee on Public Accounts (PACP) motion related to the discloser on vaccine contracts Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's life sciences & biomanufacturing strategy Monitoring and engaging on the Government’s commitment to create a national strategy for rare diseases; the Canadian Drug Agency; and C64, An Act to Implement pharmacare. Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries Engage the Federal Government on Health Canada’s Regulatory Innovation Agenda (Agile Licensing Modernization) to discuss opportunities for further harmonization; flexibility and predictability in the new regulatory framework being develop and its linkage to pillar 5 of the Biomanufacturing and Life Sciences Strategy. Discussions on the procurement of a COVID19 vaccine and therapy Discussions around the World Trade Organization consideration of a TRIPS Patent Waiver and the World Health Organization pandemic treaty proposal Consider amendments to the Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of potential importation legislation in the United States. Advocacy to maintain and increase funding for the National Immunization Strategy and discussions on vaccine procurement.

The company is pursuing procurement opportunities with both Canadian and international governments for its multi-purpose armoured vehicle.

Opportunities for the Canadian Light Utility Vehicle (LUV) procurement using Canadian made steel to support domestic jobs and manufacturing. New opportunities for Canadian defence procurements and other buy Canadian opportunities such as infrastructure and transportation. Potential new policies, regulations, or international agreements impacting Canada’s international trade framework, with implications for the steel industry. Federal government priorities and policies related to the international trade of steel and improve the competitiveness of the domestic steel industry. Support measures for steel industry and workers based on domestic economic conditions, increased tariffs, and ongoing global trade issues.

Monitoring provided to ensure compliance with the provisions and regulations of the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union, particularly those concerning access to public procurement markets in member countries. The representations are intended to promote Bell's interests in relation to the Agreement between the European Union and Canada concerning participation under the SAFE Instrument (Security Action for Europe) through the Reinforcement of the European Defence Industry. Représentations auprès du gouvernement du Canada ayant comme objectif l'obtention de financement pour le développement et la commercialisation de nouveaux hélicoptères Bell ou pour la réalisation de programmes de recherche et développement. Fourniture éventuelle d'appareils dans le cadre du projet nTACS (next Tactical Aviation Capability Set) au ministère de la défense nationale. Représentations dans le but d'encourager l'achat et/ou la location d'hélicoptères Bell et leurs services et support associés par le gouvernement du Canada. Représentations afin d'offrir au gouvernement du Canada une solution canadienne pour l'approvisionnement d'hélicoptères fabriqués au Canada afin de venir en aide aux forces militaires ainsi qu'aux services publics à travers le monde en appui aux opérations humanitaires et de sauvetage auprès des populations civiles. Discussions et représentations afin que le gouvernement du Canada maintienne, bonifie et/ou mettre en place des programmes et des politiques d'appui à l'industrie canadienne de l'aérospatiale.

Discussions about Canada’s defence procurement strategies as well as Canada's energy policies with respect to rules governing trade between Canada and the United States Considerations for R&D/funding with respect to Security and Defence systems including Intelligence Systems, Surveillance and Reconnaissance, Maritime Multi-Mission, Strategic Mobility, Escort Helicopter, Search and Rescue, Weapons programs, energy programs and IT/Information Solutions. Defence policy programs for the Department of National Defence, marketing of new product introduction, In-Service contracts for products concerning existing and future Boeing capabilities in Canada. Defence procurement, with respect to policy instruments and procurement strategy applied in the context of defence contracting. Industrial Technological Benefits policy including the application of the policy to future defence procurements. Applicability of investments by Boeing Canada to existing Canadian Government Programs